5 Selective Inhibitors of Cyclooxygenase-2 (COT-2)
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 36, 201-234
- https://doi.org/10.1016/s0079-6468(08)70048-1
Abstract
No abstract availableThis publication has 125 references indexed in Scilit:
- Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 SelectivityJournal of Medicinal Chemistry, 1997
- A 4-Week, Double-Blind, Parallel-Group Study to Compare the Gastrointestinal Effects of Meloxicam 7.5 mg, Meloxicam 15 mg, Piroxicam 20 mg and Placebo by Means of Faecal Blood Loss, Endoscopy and Symptom Evaluation in Healthy VolunteersRheumatology, 1996
- Pharmacology of Meloxicam, A New Non-Steroidal Anti-Inflammatory Drug with an Improved Safety Profile Through Preferential Inhibition of COX-2Rheumatology, 1996
- Meloxicam in Osteoarthritis: A 6-Month, Double-Blind Comparison with Diclofenac SodiumRheumatology, 1996
- A Double-Blind, Three-Week Study to Compare the Efficacy and Safety of Meloxicam 7.5 mg and Meloxicam 15 mg in Patients with Rheumatoid ArthritisRheumatology, 1996
- A Review of the Clinical Pharmacokinetics of MeloxicamRheumatology, 1996
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Synthesis of 5-Methanesulfonamido-6-(2,4-Difluorophenylthio)-1-IndanoneSynthetic Communications, 1995
- A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2)Inflammation Research, 1995
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984